Health ❯ Medicine ❯ Pharmaceuticals
Leucovorin Chronic Obstructive Pulmonary Disease Obstructive Sleep Apnea Zepbound FDA Regulations Alzheimer's Disease FDA Novel Medicine Iloprost Alzheimer's Treatment Wegovy FDA Decisions Mifepristone FDA Advisory Committee Lupus Nephritis
Regulators limited the relaunch to one regimen because safety concerns offset strong efficacy data.